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Objective. The aim of this study was to compare the immunohistochemical expression of nuclear factor B (NF-B),
matrix metalloproteinase 9 (MMP-9), and CD105 in odontogenic keratocysts (OKCs), dentigerous cysts (DCs), and
radicular cysts (RCs).
Study design. Twenty cases of OKCs, 20 DCs, and 20 RCs were analyzed. A labeling index (LI), which expresses the
percentage of NF-B–stained nuclei, was calculated for the analysis of NF-B expression. Expression of MMP-9 in the
epithelium and in the capsule of each lesion was scored as 0 (10% stained cells), 1 (10%-50% stained cells), or 2
(50% stained cells). In addition, MMP-9 immunostaining was analyzed in endothelial cells of vessels with a
conspicuous lumen. The angiogenic index was determined based on the number of anti-CD105 antibody–stained
microvessels.
Results. In the epithelial component, the NF-B LI was higher in OKCs than in DCs and RCs (P  .001). Analysis of
MMP-9 expression in the epithelial component showed a predominance of score 2 in OKCs (90%), DCs (70%), and
RCs (65%; P  .159). Evaluation of the NF-B LI according to the expression of MMP-9 in the epithelial lining
revealed no significant difference between lesions (P  .282). In the fibrous capsule, the highest percentage of MMP-
9–stained cells (score 2) was observed in OKCs (P  .100). Analysis of the expression of MMP-9 in the vessels of
odontogenic cysts showed a predominance of score 2 in OKCs (80%) and RCs (50%) and of score 1 in DCs (75%;
P  .002). Mean microvessel count was high in RCs (16.9), followed by DCs (12.1) and OKCs (10.0; P  .163). No
significant difference in microvessel count according to the expression of MMP-9 was observed between groups (P 
.689).
Conclusions. The results suggest that the more aggressive biologic behavior of OKCs is related to the higher
expression of MMP-9 and NF-B in those lesions. The differences in the biologic behavior of the lesions studied do
not seem to be associated with the angiogenic index. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:
476-483)Odontogenic cysts comprise a group of osseodestruc-
tive lesions that frequently affect the jaws. These cysts
can arise from epithelial components of the tooth germ,
the reduced epithelium of the enamel organ, epithelial
rests of Malassez, remnants of dental lamina, or the
basal layer of the oral epithelium.1,2
The odontogenic keratocyst (OKC), recently re-
classified by the World Health Organization as a
keratocystic odontogenic tumor,3 is a developmental
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476cyst characterized by an aggressive nature and high
rate of recurrence, especially compared with other
odontogenic cysts.4 The dentigerous cyst (DC) is the
most common developmental odontogenic cyst and
usually associated with the crowns of impacted per-
manent teeth. This cyst shows an indolent behavior,
and recurrence is rare after removal.2,4,5 The radic-
ular cyst (RC) is an odontogenic cyst of inflamma-
tory origin that arises from the inflammatory stimu-
lation of the epithelial rests of Malassez.6,7 RCs,
DCs, and OKCs show distinct growth patterns and
biologic behaviors. Previous studies have investi-
gated transcription factors and factors related to tis-
sue remodeling and angiogenesis which might be
associated with the development of these lesions in
an attempt to determine which factors that may be
responsible for the specific biologic behavior of each
type of lesion.4
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transcription factors8 that regulates the expression of
various genes, including matrix metalloproteinase 9
(MMP-9) and vascular endothelial growth factor genes
whose products are involved in tumorigenesis.9 How-
ever, little is known about the role of NF-B in odon-
togenic lesions.10
MMPs comprise a family of calcium- and zinc-de-
pendent enzymes that are able to degrade extracellular
matrix components under both physiologic and patho-
logic conditions.11-13 Studies suggest that enzymatic
degradation of the bone matrix and basement mem-
brane by MMP-9 and other metalloproteinases is in-
volved in the expansion of odontogenic cysts.14-16
Endoglin, also known as CD105, is a transmembrane
protein that is highly expressed on human vascular
endothelial cells.17 Unlike panendothelial antibodies,
such as CD31, CD34, and factor VIII, endoglin is able
to distinguish endothelial cells proliferating from pre-
existing blood vessels. Several studies emphasize the
involvement of CD105 in blood vessel formation and
that its utility as a powerful marker for the quantifica-
tion of microvessels in many types of tumors.18
In view of the distinct clinical behaviors of OKCs,
RCs, and DCs the objective of the present investiga-
tion was to compare the immunohistochemical ex-
pression of NF-B, MMP-9, and endoglin between
these lesions.
MATERIALS AND METHODS
Twenty cases each of OKC, DC, and RC were stud-
ied. Formalin (10%)–fixed and paraffin-embedded
specimens were selected among cases diagnosed and
archived at the Pathologic Anatomy Service of the
Discipline of Oral Pathology, Department of Dentistry,
Federal University of Rio Grande do Norte (UFRN),
Natal, Brazil. The study was approved by the Ethics
Committee of UFRN (protocol no. 094/09).
Immunohistochemical method
Paraffin-embedded material was cut into 3-m-thick
sections and the specimens mounted on glass slides
prepared with organosilane coupling agent (3-amino-
propyltriethoxysilane; Sigma Chemical Co., St. Louis,
MO, USA). The tissue sections were deparaffinized,
submitted to antigen retrieval with citrate (pH 6.0) in a
Pascal pressure cooker (Dako, Carpinteria, CA, USA),
and then immersed in 10 volumes of hydrogen peroxide
to block endogenous peroxidase activity. Next, the sec-
tions were washed in phosphate-buffered saline solu-
tion (PBS). After treatment with normal serum, the
sections were incubated with the following primary
antibodies in a moist chamber: anti–NF-B (clone sc-
109; Santa Cruz Biotechnology, Santa Cruz, CA, USA;dilution 1:100, 180 minutes), anti–MMP-9 (clone 2C3;
NovoCastra, Newcastle upon Tyne, U.K.; dilution 1:80,
overnight), and anti-CD105 (clone SN6h; Dako; dilu-
tion 1:500, overnight). The sections were washed twice
Fig. 1. Immunohistochemical reactivity for NF-B in epithe-
lial tissue: (A) Odontogenic keratocyst; (B) dentigerous cyst;
(C) radicular cyst (LSAB, 400).in PBS and incubated with the labeled streptavidin-
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activity was developed by immersion of the sections in
diaminobenzidine (D5637; Sigma Chemical Co.). Fi-
nally, the sections were counterstained with Mayer
hematoxylin, covered with a glass coverslip, and
mounted in Permount (SP15-500; Fisher Scientific, Fair
Lawn, NJ, USA).
Prostate carcinoma and kidney and liver fragments
were used as positive control samples for NF-B,
MMP-9, and CD105, respectively. The negative control
involved substitution of the primary antibody with 1%
bovine serum albumin in PBS.
Analysis of the immunohistochemical profile
The slides were examined under a light microscope
(Olympus Cx31; Tokyo, Japan) at 400 magnification.
NF-B staining was analyzed by an adaptation of the
method proposed by Nakayama et al.19 For this pur-
pose, 1,000 epithelial cells were counted in 5 different
representative fields of the cystic lesions. A labeling
index (LI), which expresses the percentage of NF-B-
immunostained nuclei, was calculated based on the
number of immunopositive nuclei.
MMP-9 staining was evaluated according to Gong
et al.,10 with some modifications. Ten histologic
fields each were selected in the epithelial component
and in the connective tissue capsule. Immunoexpres-
sion of MMP-9 was scored in each case as 0 (10%
immunostained cells), 1 (10%-50% immunostained
cells), or 2 (50% immunostained cells). In addi-
tion, expression of MMP-9 was analyzed in endothelial
cells of vessels with a conspicuous lumen at 400 mag-
nification, selecting 5 fields that showed the highest im-
munoreactivity.
The angiogenic index of OKCs, DCs, and RCs was
determined by the quantification of anti–CD105-im-
munoreactive vessels by an adaptation of the method
of Maeda et al.20 Ten areas of highest anti-CD105
immunoreactivity were identified at 40 magnifica-
Table I. Parameters used for the calculation of the Kru
(LI) of nuclear factor (NF) B nuclear staining in epith
of radicular cyst, dentigerous cyst, and odontogenic ke
n Median
NF-B (LI)
Odontogenic keratocyst 20 21.7
Dentigerous cyst 20 4.8
Radicular cyst 20 1
CD-105 (angiogenic index)
Odontogenic keratocyst 20 6.1
Dentigerous cyst 20 7.4
Radicular cyst 20 17.5tion and the microvessel count (MVC) was obtainedby counting immunostained vessels in these areas at
200 magnification.
Statistical analysis
The results were analyzed with the use of the Statis-
tical Package for the Social Sciences (version 17.0;
SPSS, Chicago, IL, USA). NF-B LIs in the epithelium
were compared between the different cysts by the non-
parametric Kruskal-Wallis test. For the analysis of
MMP-9 expression, scores 0 and 1 were combined into
one group and score 2 remained as another group.
Differences in MMP-9 expression in the cystic epithe-
lium and in the connective tissue capsule were evalu-
ated by the 2 test. Differences between NF-B LIs
according to MMP-9 expression in the cystic epithe-
lium were evaluated by the nonparametric Mann-Whit-
ney test. The Kruskal-Wallis test was used for the
comparison of the number of CD105-immunostained
blood vessels. Possible differences in MVC according
to the expression of MMP-9 in the vessels of odonto-
genic cysts were evaluated by the nonparametric Mann-
Whitney test. A level of significance of 5% (P  .05)
was established for all tests.
RESULTS
The mean NF-B LI in the epithelial lining was
higher in OKCs (21.1%, range 3.7%-44.2%) than in
DCs (8.7%, range 0.2%-31.6%) and RCs (1.4%, range
0.2%-5.5%; Fig. 1). Nonparametric tests revealed sig-
nificant difference between groups (P  .001; Table I).
Regarding the epithelial expression of MMP-9, there
was a predominance of score 2 (n 18; 90%) in OKCs,
whereas score 1 was predominantly observed in the
other 2 cases (10%). Similarly, score 2 predominated in
DCs (n  14; 70%), but the distribution of scores 0
(n  4; 20%) and score 1 (n  2; 10%) was relatively
similar. In RCs, most cases were classified as score 2
(n  13; 65%), followed by score 1 (n  5; 25%) and
allis test (KW) for the evaluation of the labeling index
tissue and evaluation of the angiogenic index (CD105)
st
















0score 0 (n  2; 10%; Fig. 2). Statistical analysis re-
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0.159; Table II).
Evaluation of the NF-B LI according to the level of
MMP-9 expression in epithelial cells lining the cysts
Fig. 2. Immunohistochemical reactivity for MMP-9 in epi-
thelial and conjuntive tissues: (A) Odontogenic keratocyst;
(B) dentigerous cyst; (C) radicular cyst (LSAB, 400).showed a mean index of 8.9% (range 0.2%-44.2%) forcysts scored as 1. On the other hand, cysts scored as 2
presented a mean LI of 10.9% (range 0.2%-39.2%).
Nonparametric Mann-Whitney test revealed no signif-
icant difference between groups (P  .282). Similarly,
separate analysis of OKCs, DCs, and RCs showed no
significant differences in NF-B LI according to the
level of MMP-9 expression in the epithelial lining (P 
.313; P  .650; and P  .721; respectively).
Analysis of the expression of MMP-9 in the capsule
of the lesions studied showed a relatively similar dis-
tribution of score 1 (n  8; 40%) and score 2 (n  9;
45%) in OKCs. Score 0 was observed in 15% of cases
(n  3). In contrast, in DCs there was a similar distri-
bution of score 0 (n  8; 40%) and score 1 (n  9;
45%), whereas score 2 was observed in 15% of cases
(n  3). In RCs, there was a predominance of score 2
(n  11; 55%), followed by score 3 (n  5; 25%) and
score 0 (n  4; 20%; Fig. 2). Statistical analysis
showed no significant difference between groups (P 
.100; Table II).
Analysis of the expression of MMP-9 in vessels of
the odontogenic cysts showed a predominance of score
2 (n  16; 80%), followed by score 1 (n  4; 20%), in
OKCs. DCs presented a higher percentage of cases
classified as score 1 (n  15; 75%), followed by score
2 (n  4; 20%) and score 0 (n  1; 5%). In RCs, there
was a similar distribution of cases scored as 1 (n  9;
45%) and 2 (n  10; 50%). Only 1 case (5%) was
classified as score 0. The 2 test revealed a significant
difference between groups (P  .002; Table II).
Regarding angiogenesis, the highest mean MVC was
obtained for RCs (16.9, range 2.0-44.0), followed by
DCs (12.1, range 0.0-48.0) and OKCs (10.0, range
1.7-39.0; Fig. 3). However, the Kruskal-Wallis test
revealed no significant difference in MVC between
groups (P  .163; Table I).
Analysis of MVC according to the level of expres-
sion of MMP-9 in endothelial cells revealed a mean
count of 13.9 vessels (median 15.4, range 0.0-48.0) for
cysts with score 0/1, whereas cysts scored as 2 had a
mean count of 12.2 vessels (median of 8.16, range
1.7-39.0). There was no significant difference between
groups (P  .689; nonparametric Mann-Whitney test).
Similarly, separate analysis of OKCs, DCs, and RCs
showed no significant differences in MVC according to
the level of MMP-9 expression in endothelial cells
(P  .965; P  .965; P  .676; respectively).
DISCUSSION
DCs are the most common developmental cysts. In
the past, it was believed that the epithelial lining of
these cysts has a higher proliferative potential than the
epithelial lining of inflammatory cysts, such as RC.7
OKCs are one of the most frequent odontogenic lesions
20 (10
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biologic behavior and tendency toward recurrence.21,22
Studies have demonstrated a high proliferative activity
of these lesions and the expression of proteins associ-
ated with the inhibition of apoptosis,23,24 in addition to
the observation of allelic losses, especially in the P16,
P53, PTCH, MCC, TSLC1, LTAS2, and FHIT genes.25
In view of OKC’s aggressive biologic behavior,
studies have tried to identify the molecular basis un-
derlying the distinct behavior of OKCs compared with
other odontogenic cysts. The present study evaluated
the immunohistochemical expression of NF-B,
MMP-9, and CD105 in DCs, RCs, and OKCs and
compared the expression of these markers between
lesions.
In quiescent cells, the nuclear transcription factor
NF-B is sequestered in the cytoplasm by IB pro-
teins.26 Its activation by cytokines requires the phos-
phorylation and degradation of the cytoplasmic inhibi-
tor IB.27 Once activated, NF-B is translocated to
the nucleus, where it induces the expression of a set
of target genes, including those involved in tumor me-
tastasis, cell-cycle regulatory genes, and growth factor
genes, in addition to regulating MMP genes, such as
MMP-9.8 Therefore, activated NF-B plays an impor-
tant role in cell differentiation, proliferation, and apo-
ptosis in response to a variety of physiologic and patho-
logic stimuli. Studies have shown that NF-B activity
can be detected in cells of different tumors, but little is
known about its role in odontogenic lesions.10
In a comparative study of ameloblastomas and tooth
germs, Kumamoto and Ooya28 observed scarce nuclear
NF-B staining in both tumors and normal odontogenic
epithelium. Similarly, Gong et al.,10 analyzing NF-B
Table II. Distribution of cases of radicular cysts, dent
percentage of cells stained by MMP-9 in epithelium, fi
Odontogenic keratocyst De
Epithelial tissue
10% (score 0) 0 (0)
10%-50% (score 1) 2 (10)
50% (score 2) 18 (90)
Total 20 (100)
Fibrous capsule
10% (score 0) 3 (15)
10%-50% (Score 1) 8 (40)
50% (Score 2) 9 (45)
Total 20 (100)
Blood vessels
10% (score 0) 0 (0)
10%-50% (score 1) 4 (20)
50% (score 2) 16 (80)
Total 20 (100)staining in calcifying odontogenic cysts and classicameloblastomas, found scarce nuclear staining (1%)
in the 2 groups. Despite these findings, an association
between higher NF-B expression and greater aggres-
siveness has been demonstrated for different malignant
tumors.27,29,30
In the present study, a significant difference in the
NF-B LI was observed among OKCs, DCs, and RCs,
with a higher mean index (21.1%) in OKCs. Therefore,
the higher nuclear expression of this factor in OKCs
might be related to the greater aggressiveness of those
tumors compared with DCs and RCs.
NF-B regulates the expression of a large number of
proinflammatory cytokines, such as tumor necrosis fac-
tor , interleukin-1, and interleukin-6, as well as
MMPs.31 MMPs are important proteases that cause
structural and functional changes in extracellular matrix
components. Under physiologic conditions, MMPs
are poorly expressed in tissues. However, overex-
pression of these proteins is observed under patho-
logic conditions, which is the result of an imbalance
between the activity of MMPs and their inhibitors
(TIMPs).12
Among MMPs, gelatinase B (MMP-9) plays an im-
portant role in angiogenesis as well as in tumor inva-
sion and metastasis, mainly because of its capacity to
cleave collagen IV present in the basement mem-
brane.32 Despite the small number of studies involving
odontogenic lesions, the expression of MMP-9 was
demonstrated in ameloblastoma, calcifying cystic
odontogenic tumor, dentinogenic ghost cell tumor,
odontogenic ghost cell carcinoma, OKC, DC, and
RC.10,12,16 Kubota et al.,33 investigating whether the
latent (92 kDa) or active (83 kDa) form of MMP-9 is
present in fluids of OKCs, DCs, and RCs, observed
s cysts, and odontogenic keratocysts according to the
capsule, and blood vessels, n (%)




























4 (20the presence of the active form in 75% of OKCs and
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these findings, in the present study MMP-9 expression
tended to be higher in epithelial cells of OKCs com-
pared with DCs and RCs (P .05). Immunohistochem-
Fig. 3. Immunohistochemical reactivity for CD-105 in endo-
thelial cells: (A) Odontogenic keratocyst; (B) dentigerous
cyst; (C) radicular cyst (LSAB, 400).istry is unable to differentiate between the latent andactive forms of proteins. However, in a study by Ikebe
et al.,34 MMP activity analyzed by zymography showed
a significant correlation with immunohistochemical
staining.
In an attempt to elucidate the molecular basis under-
lying the more aggressive biologic behavior of OKCs
compared with DCs and RCs and in view of the higher
nuclear NF-B staining in OKCs observed in the pres-
ent study, we analyzed NF-B LIs according to the
expression of MMP-9 in the epithelial cells lining these
lesions. Despite the lack of a significant difference,
MMP-9 expression by epithelial cells tended to be
higher in OKCs compared with DCs and RCs. This
finding suggests a possible role of NF-B as a tran-
scription factor of this metalloproteinase, because, like
MMP-9 expression, the activated factor was detected in
the epithelium of most OKCs. This fact has also been
reported in the literature by dell’Agli et al.,8 who sug-
gested that NF-B acts as a transcription factor, and by
Garg and Aggarwal,9 who reported a role of this factor
as a regulator of MMP-9 gene expression.
Regarding the expression of MMP-9 in the fibrous
capsule of the odontogenic lesions studied, the ten-
dency toward higher expression of this protein in the
fibrous capsule of OKCs compared with DCs and RCs
observed in the present study agrees with the findings
reported by Silveira et al.16 Kumamoto et al.,35 analyz-
ing the expression of MMP-9 in ameloblastomas, also
detected strong reactivity to this metalloproteinase in
the stroma of these tumors, suggesting that an increased
production of this protein by neoplastic cells is related
to the neoplastic transformation of odontogenic tissues
and aggressiveness of these tumors. Taken together,
these findings and the results of the present study sug-
gest that the higher expression of MMP-9 in the mes-
enchymal component of OKCs contributes to the more
aggressive behavior of these tumors compared with
inflammatory cysts and DCs by promoting the degra-
dation of extracellular matrix. In contrast, expression of
MMP-9 in epithelial cells might be responsible for the
degradation of the basement membrane.
Different methods are available for the evaluation
of angiogenesis in biologic material, including MVC
and the determination of microvessel density and
volume.36-38 Among these methods, MVC is an easy
technique that has prognostic relevance in different
tumors.38,39
One widely used angiogenic marker is endoglin, or
CD105, which was originally identified as a human
endothelial marker although subsequent studies dem-
onstrated that this cell surface antigen is also expressed
by macrophages, erythrocyte precursors, and stromal
cells.40 Endoglin binds to various transforming growth
factor 	 isoforms and exhibits high affinity for human
OOOOE
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angiogenesis and is considered to be a powerful marker
of neovascularization.41
In the present study, mean MVC was higher in RCs
than in DCs and OKCs (P  .163). Despite the lack of
reports using MVC for the evaluation of angiogenesis
in these lesions, in a comparative study of microvessel
density between OKCs and RCs, Tete et al.42 observed
higher vascularization in RCs. The higher mean MVC
in RCs seen in the present study might be related to the
presence of an exuberant inflammatory infiltrate in
these lesions, because, according to Graziani et al.43
and Nonaka et al.,6 inflammatory cells can exert angio-
genic activity in these cysts.
In the present study, MVC was higher in DCs than in
OKCs. These results differ from those reported by
Alaeddini et al.4 who observed higher microvessel den-
sity in OKCs compared with DCs. One possible expla-
nation for this difference is the fact that in the latter
study microvessel density was evaluated based on im-
munoreactivity to the anti-CD34 antibody, whereas in
the present investigation CD105 immunostaining was
used for microvessel quantification.
In addition, analysis of MVC according to the ex-
pression of MMP-9 in endothelial cells revealed no
significant difference between OKCs, DCs, and RCs. In
fact, the role of MMP-9 in the development of the
lesions studied might be associated with the regulation
of other factors unrelated to angiogenesis, such as fac-
tors involved in cell proliferation and migration, apo-
ptosis, and immune and inflammatory responses.44
In conclusion, the present results suggest that the
more aggressive biologic behavior of OKCs compared
with RCs and DCs is related to the higher expression of
MMP-9 and NF-B in these lesions. In addition, dif-
ferences in the biologic behavior of the lesions studied
do not seem to be associated with the angiogenic index.
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